Infant formula containing galacto-and fructo-oligosaccharides and <i>Bifidobacterium breve</i> M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study.

Abrahamse-Berkeveld, M; Alles, M; Franke-Beckmann, E; Helm, K; Knecht, R; Köllges, R; Sandner, B; Knol, J; Ben Amor, K; Bufe, A

Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study.

Abrahamse-Berkeveld, M; Alles, M; Franke-Beckmann, E; Helm, K; Knecht, R; Köllges, R; Sandner, B; Knol, J; Ben Amor, K; Bufe, A.

Afiliação

Abrahamse-Berkeveld M; Nutricia Research, Utrecht, The Netherlands.
Alles M; Nutricia Research, Utrecht, The Netherlands.
Franke-Beckmann E; NETSTAP e.V., Bochum, Germany.
Helm K; NETSTAP e.V., Bochum, Germany.
Knecht R; NETSTAP e.V., Bochum, Germany.
Köllges R; NETSTAP e.V., Bochum, Germany.
Sandner B; NETSTAP e.V., Bochum, Germany.
Knol J; Nutricia Research, Utrecht, The Netherlands.
Ben Amor K; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.
Bufe A; Nutricia Research, Utrecht, The Netherlands.

J Nutr Sci ; 5: e42, 2016.

Article em En | MEDLINE | ID: mdl-28620469

Palavras-chave

Bifidobacterium breve M-16V; Hydrolysed formula; ITT, intention-to-treat; Infant growth; PP, per-protocol; RMMM, repeated-measures mixed model; Randomised controlled trials; SCORAD, SCORing Atopic Dermatitis; Synbiotics; scGOS/lcFOS, short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google